Indonesia’s Drug Formulary Short On Generic Equivalents
This article was originally published in PharmAsia News
Indonesia’s national drug formulary underpins aims to increase access to medicines under the phased launch of universal health care. But with 40% of the drugs lacking generic equivalents, concerns have been raised about costs and supply.
You may also be interested in...
A new economic stimulus package from the Indonesian government that includes allowing up to 100% foreign ownership in the pharmaceutical and health sectors has been welcomed by the multinational industry.
An edict by a top Muslim council in Indonesia that the country’s national health insurance does not follow Islamic sharia law principles has sparked debate in the world’s most populous Muslim-majority country.
Indonesia’s national health insurance operator is seeking an increase in premiums as it struggles with deficits amid soaring claims within the system.